ESPL1 and myelodysplastic syndrome: In search for novel predictive markers we have investigated the context between separase activity and MDS progression by comparatively analyzing separase proteolytic activity, karyotype, centrosomal, mutational and clinical status in a total of 67 bone marrow samples derived from MDS, sAML, de novo AML patients and corresponding healthy control donors.